Articles tagged with Cancer Screening
A study published in The Journal of the National Cancer Institute found that computed tomographic colonography (CTC) screening every five years is not cost-effective if reimbursed at the same rate as colonoscopy. However, CTC would be cost-effective if it enticed 25% more individuals to screen.
A new study published in Psychological Science found that men are less likely to seek cancer screening when presented with misleading information about the prevalence of screening among other men. The researchers suggest that framing health messages to emphasize the benefits of screening rather than relying on relative numbers can be a...
A 14-year randomized controlled trial shows that prostate cancer screening significantly reduces mortality rates. The study found that men screened for prostate-specific antigen (PSA) had a lower risk of dying from prostate cancer compared to those not screened.
The authors propose a new paradigm for breast cancer screening, shifting focus from mammography to more effective early detection methods. Behavioral interventions appear to have limited impact on repeat screening rates, and media attention highlights the flaws of current technologies.
A recent meta-analysis found that there is no single best intervention for promoting repeat breast cancer screening with mammography. The studies were heterogeneous, differing in their conclusions about similar interventions due to a lack of standardization among interventions or different populations and settings.
A study estimates that 1.58 million US cancer survivors live with their 2.85 million children, and 562,000 minor children live with a parent in early cancer treatment and recovery. Most of these survivors are female, married, and under 50 years old.
Rates of cancers affecting skin appendages such as sweat glands and mammary glands are rising in the US. Incidence increased by 150% between 1978-1982 and 2002-2005, with age being a key factor.
Clinical guidelines recommend screening low-risk women every three years after age 30, but most primary care clinicians advocate for more frequent testing. Annual Pap testing has helped decrease cervical cancer burden, but cost-effectiveness models suggest overuse may increase costs with little improvement in outcomes.
A population-based study of 2,071 Hodgkin lymphoma survivors over 15 years found that many did not receive recommended cancer screening tests. Despite frequent contact with doctors and primary care providers, survivors often lacked screenings for other cancers, including colorectal, breast, and cervical cancer.
The American Society for Gastrointestinal Endoscopy (ASGE) has issued guidelines addressing ethnicity and gastrointestinal diseases. The guideline recommends that colorectal cancer screening begin at age 45 for average-risk African-American men and women, emphasizing the importance of early detection in reducing mortality rates.
Researchers found that CA-125 change over time can detect invasive, high-grade ovarian cancers at curable stages in post-menopausal women. The study identified a promising first step towards screening, but acknowledges the need for further research and a large-scale randomized trial to confirm the findings.
A study of 117,738 women aged 18-39 found that screening mammograms had poor accuracy and high recall rates for additional tests. Diagnostic mammograms performed due to symptoms had better accuracy and detection rates.
A new 16-year study found that a single flexible sigmoidoscopy examination in men and women aged 55-64 reduced bowel cancer incidence by a third. The test halved incidence in the lower bowel, leading to a 43% reduction in mortality. Researchers believe screening with this procedure could save thousands of lives.
A recent review found that approximately 25% of breast cancers and 60% of prostate cancers detected by screening tests may not be destined to cause symptoms or death due to overdiagnosis. This phenomenon leads to unnecessary treatment and other harms, emphasizing the need for strategies to address it.
A new study reveals that Hispanics living in areas with low endoscopy capacity are less likely to undergo colorectal cancer screening. The study found a modest increase in screening rates as endoscopy capacity improved, suggesting that addressing local capacity constraints could help reduce disparities in screening.
A new study by the National Cancer Institute found that health care utilization, rather than biology, plays a more important role in colorectal cancer disparities among African Americans. The study revealed that blacks were less likely to receive follow-up colonoscopies after screening, leading to delayed diagnosis and treatment.
A recent study found that blacks in the US are less likely to follow up on abnormal colon cancer screening test results, highlighting disparities in healthcare utilization. The study analyzed data from a large national trial and found that 62.6% of black participants went for a diagnostic colonoscopy, compared to 72.4% of white partici...
A large-scale study of 10,000 adults found that virtual colonoscopy identifies more unsuspected cancers outside the colon than within it. The majority of these cancers were detected at an early stage and have positively affected survival.
Researchers at Boston University School of Medicine found sociodemographic characteristics significantly influence a patient's willingness to participate in cancer screenings. Lower education and income levels are associated with lower rates of cancer screenings, leading to potential disparities in mortality rates.
A study published in Radiology found that computed tomographic colonography (CTC), or virtual colonoscopy, is a safe and effective screening tool for older adults. The advanced neoplastic prevalence was 7.6 percent, with no significant difference in accuracy compared to younger patients.
Research from the CISNET network finds that biennial screening reduces breast cancer mortality by 16.5% and false-positive rates by half, while minimizing unnecessary biopsies and anxiety.
Primary HPV DNA screening with cytology triage is more sensitive than conventional screening for detecting cervical lesions, especially among older women. This approach can lead to fewer colposcopy referrals and follow-up tests.
A recent study by Grace X. Ma found that cancer screening rates differ greatly across Asian subgroups in the US, with some groups facing significant barriers to care due to language and cultural differences. The study highlights the need for culturally sensitive interventions to address these disparities.
A decline in invasive breast cancer cases was observed in Spanish women starting in 2001, following a period of increasing rates from the 1980s and 1990s. The trend is attributed to screening saturation, which reduced the pool of undiagnosed prevalent cases.
Current screening programs have not significantly decreased deaths from breast and prostate cancers, despite high costs and increased treatment. Experts recommend focusing on identifying patients at risk for aggressive cancers and developing new tools to improve screening.
A survey of resident physicians found that many are not trained in skin cancer examinations, with only a small percentage reporting skill levels in performing the procedure. The study highlights the need for comprehensive training programs to teach this essential skill.
A study found that 50% of families with a genetic risk of bowel cancer declined genetic testing due to fear of insurance rejection. Researchers urge the Australian government and insurance industry to reconsider their stance on genetic information, which can reduce morbidity and mortality.
Researchers estimated that 1.3 million extra cases were diagnosed and over a million treated since 1986 due to overdiagnosis of prostate cancer through PSA screening. The majority of these cases involve younger men.
A new study published in the Journal of the National Cancer Institute found that adding clinical breast examination to mammography improves breast cancer detection rates and sensitivities, but also leads to higher false-positive rates. The study used a cohort of over 290,000 women screened between 2002 and 2003.
A Chinese study establishes a multifaceted barrier-focused intervention program to increase colonoscopy attendance among nonadherent high-risk populations for colorectal cancer screening. The program significantly increased attendance rates, especially among those with objective barriers.
A new study published in the Journal of the National Cancer Institute found that fecal DNA methylation can detect gastric and colorectal cancers. Methylation patterns were more likely to be found in advanced tumors, with detection rates of 57% for gastric cancer patients and 75% for colorectal cancer patients.
A recent report by the American Association for Cancer Research finds that cancer mortality rates have declined steadily across all age groups over the past three decades. The decline is attributed to improved screening and treatment methods, with even younger individuals experiencing significant reductions in mortality rates.
A study in Korea found that individuals with low income, education level, and unhealthy behaviors tend to not use gastric cancer screening services. Targeted interventions and public campaigns can help improve screening participation for these vulnerable populations.
A public survey in Europe found that most people overestimate the life-saving benefits of breast and prostate cancer screening. The study's findings highlight the need for accurate screening messages to include risks associated with overdiagnosis and overtreatment.
A recent study found that digital mammography significantly increases breast cancer detection rates, outperforming film-screen technology. The switch led to a notable rise in cancers detected at San Luis Diagnostic Center, averaging 7.9 cancers per 1,000 women imaged.
A University of North Carolina study found that establishing a regular relationship with a healthcare provider reduces racial disparities in prostate cancer diagnosis. Men with ongoing relationships are more likely to receive screenings and less likely to be diagnosed with advanced disease.
Researchers developed models to understand the growth and progression of serous ovarian cancer, identifying key properties for a biomarker-based screening test. The study aimed to guide rational design of an early detection strategy, potentially leading to improved outcomes for women diagnosed with this aggressive type of ovarian cancer.
Long-term adult cancer survivors face a higher risk of experiencing serious psychological distress due to effects on physical health and social adaptation. Approximately 5.6% of cancer survivors screened positive for severe psychological distress within the previous 30 days.
Researchers identified that even among high-risk groups, only a few individuals had invasive bladder cancer, highlighting the need to find a higher-risk group to benefit from screening. Abstaining from smoking is crucial in preventing bladder cancer.
A decision-analytic model suggests that more frequent and strict colonoscopy recommendations can be cost-effective strategies for screening second primary colorectal cancers in male cancer survivors. The most vulnerable population aged 40 years old may benefit from COL5, while the general population aged 50 years old may follow COL10.
A study found that CT scans used to screen for coronary artery calcification could lead to an estimated 42 additional radiation-induced cancer cases per 100,000 men and 62 cases per 100,000 women. The wide dose variation from different scanners resulted in a wide range of estimated radiation-induced cancer risks.
Several statistical and biological issues need to be addressed to improve biomarker identification for early cancer detection. The author suggests using more frequent specimen collection and the paired availability design to enhance the biomarker pipeline.
A review of nearly 6,000 women found that lack of information and misconceptions about breast and cervical cancer significantly contribute to screening fear. The study recommends promoting education and targeting specific fears to increase uptake rates.
Australian researchers have developed gene expression biomarkers that can accurately detect pre-cancerous and cancerous colorectal growths from non-cancerous controls. This breakthrough is a result of a collaborative study involving CSIRO, Flinders University, and Clinical Genomics Pty Ltd.
A new study found that childhood cancer survivors have a significantly increased risk of developing second primary cancers throughout their lives. The research, published in the Journal of the National Cancer Institute, analyzed data from 47,697 people diagnosed with cancer before age 20 and found a higher incidence rate of new primary...
A new study published in the American Cancer Society found that people living in urban areas are more likely to develop late-stage cancer than those in suburban and rural areas. The research suggests a need for more effective urban-based cancer screening and awareness programs, particularly for vulnerable populations.
A new study found that ultrasound and blood test screening for ovarian cancer only catches the disease in its late stages, resulting in unnecessary surgery. The positive predictive value of these tests is remarkably low, leading to many false positives.
A population-based study found that HPV16 and HPV18 genotypes were present in the majority of invasive cervical cancers in New Mexico. The mean age of women diagnosed with HPV16- or HPV18-positive cancer was 5 years younger than that of women diagnosed with other HPV types, suggesting implications for future cancer screening.
A study at Duke University Medical Center suggests that ovarian cancers detected early on may be slower-growing and less likely to spread than more aggressive forms. This finding challenges the idea of screening for ovarian cancer as a means of reducing mortality.
The German colonoscopy program has prevented approximately 15,000 cases of colorectal cancer between 2003 and 2010. The program's effectiveness is attributed to the early detection of cancer precursors through endoscopic examinations.
The study found that PSA screening can reduce prostate cancer deaths by 20%, saving one life for every 1,408 men screened. The European Association of Urology's largest prostate cancer screening study provides robust evidence for the effectiveness of screening on prostate cancer mortality.
Researchers at Baylor College of Medicine identified three small molecules that block the activity of Stat 3, a key enzyme in cancer cell survival. The compounds showed promise in inducing programmed cell death in breast cancer cells, offering new hope for cancer treatment.
Researchers found that study methods and definitions of lead time significantly impact estimates of prostate cancer screening's effectiveness. The study suggests a need for clear methodology to accurately interpret findings.
The largest randomised trial of ovarian cancer screening has shown that both the CA125 blood test and transvaginal ultrasound screening strategies are capable of detecting early stage ovarian cancers. The study detected almost half of all cancers in stage I/II, with a significant improvement in specificity for multimodal screening.
Men with male factor infertility are 2.8 times more likely to develop testicular cancer than those without this condition. A total of 34 men diagnosed with testicular cancer were found in a study of 22,562 infertile men.
A new study published in BMC Public Health found that cervical cancer incidence varies among geographical areas in Southeast England, with higher rates in more deprived areas. The research analyzed data on 2,231 cases of cervical cancer diagnosed between 2001 and 2005, revealing dramatic variations within regions.
A recent study published in The Journal of Urology found that low-income men are diagnosed with more advanced prostate cancer due to inadequate access to screening services. This disparity is significant, as the study reveals that 19% of these men were diagnosed with metastatic cancer, compared to 4% in the general population.
The study found that the majority of men complied with PSA and DRE tests, with over 84% of diagnosed cancers picked up by screening. Cancer detected at baseline tended to be more serious and aggressive than those detected later.
A growing number of older adults are expected to be diagnosed with and live longer with cancer due to the aging baby boomer population. Critical issues include prevention, screening, treatment, survivorship, and end-of-life care for older adults with cancer.
A lack of clear-cut scientific evidence has created controversy over breast cancer screening for women over 80. Researchers recommend investing in clinical trials to assess cancer screening and treatment for older individuals, strengthening empirical data for medical recommendations.